{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Wilmington",
      "state": "DE",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "65543",
      "recalling_firm": "AstraZeneca Pharmaceuticals LP",
      "address_1": "1800 Concord Pike",
      "address_2": "N/A",
      "postal_code": "19850",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "USA and Puerto Rico",
      "recall_number": "D-840-2013",
      "product_description": "MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC  0310 0321 30",
      "product_quantity": "81,900 total vials",
      "reason_for_recall": "Presence of Precipitate; potential for incomplete constitution upon addition of diluent.",
      "recall_initiation_date": "20130621",
      "center_classification_date": "20130805",
      "termination_date": "20150129",
      "report_date": "20130814",
      "code_info": "NDC 0310-321-30, lot JX109, expiration 2/2015; lot JY042, expiration 2/2015"
    }
  ]
}